United States FOR PHYSICIANS ABOUT US NEWSROOM CONTACT US Who We Are Leadership Team Board of Directors Investors Careers Leadership Team Michael DeMane — President and Chief Executive Officer Michael DeMane is the President and CEO of Nevro Corp. Mr. DeMane is a veteran medical device company executive, having held leadership roles in the US, Europe and Australia over the past 30 years. His most recent operating role was COO of Medtronic, Inc., and prior to that, Medtronic’s Senior Vice President and President Europe, Canada, Latin America and Emerging Markets, in which positions he directed the company’s operations in those regions. Before joining Medtronic, Mr. DeMane served as Managing Director, Australia and New Zealand, for Smith & Nephew Pty. Ltd. Mr. DeMane has completed the Advanced Management Program at INSEAD in Fontainebleau, France. He holds an M.S. in Bioengineering from Clemson University in South Carolina and a B.S. in Chemistry from St. Lawrence University in Canton, New York. Rami Elghandour — Chief Business Officer Rami Elghandour is Chief Business Officer of Nevro Corp. Prior to joining Nevro, Mr. Elghandour was an investor with Johnson & Johnson Development Corporation (JJDC) where he led several investments including Nevro’s Series B Financing. During his tenure, Mr. Elghandour served on the Board of Directors of ten companies, including Nevro’s, and led strategic initiatives in the development and management of JJDC’s portfolio. Prior to joining JJDC, Mr. Elghandour worked for Advanced Neuromodulation Systems, Inc., (ANS) where he led firmware design and development on several implantable spinal cord and deep brain neurostimulators, including the ANS flagship Eon Rechargeable Neurostimulation System. Mr. Elghandour received a Master of Business Administration from the Wharton School of the University of Pennsylvania and holds a Bachelor of Science in Electrical and Computer Engineering from Rutgers University School of Engineering. Michael Enxing — Vice President of Sales and Marketing Michael Enxing, Vice President of Sales and Marketing of Nevro Corp, has more than two decades of executive level sales and marketing management experience, notably in the areas of pre- and post-FDA development, strategic development, product launches, Sales and Marketing team development, IPOs, and acquisitions. Prior to Nevro, Mr. Enxing served as Vice President of Vertos Medical. He has also held various executive positions at Cardio Vascular Solutions (CSI), Advanced Neuromodulation Systems (acquired by St. Jude), Stryker, and Tecnol Medical (acquired by Kimberly Clark). Mr. Enxing is a graduate of Iowa State University with a B.S. in Communications and focus in business administration. Andrew Galligan — Chief Financial Officer Andrew Galligan is Vice President of Finance and Chief Financial Officer of Nevro Corp. Before joining Nevro, Mr. Galligan held the same position at OOMA, a consumer electronics manufacturer and VOIP service provider. Prior to that, Mr. Galligan was VP Finance and CFO of Reliant Technologies, a pioneer of fractional resurfacing skin treatments with aesthetic lasers. Mr. Galligan has also held the top financial executive position at several other medical device companies, brings to Nevro many years of experience in the commercialization of innovative medical therapeutic and diagnostic technologies, and began his career in various financial positions at KPMG and Raychem. Mr. Galligan received his degree in Business Studies from Trinity College in Dublin, Ireland and he is also a Fellow of the Institute of Chartered Accountants in Ireland. Brad Gliner — Vice President, Clinical & Regulatory Brad Gliner is Vice President of Clinical and Regulatory at Nevro Corp., with over 20 years of experience in the medical device industry. Prior to joining Nevro, Mr. Gliner was Vice President of Research at Northstar Neuroscience, where he led research on numerous neuromodulation applications. He was also a co-founder of Heartstream, Inc., where first-responder defibrillation was transformed into widespread availability. Mr. Gliner received a B.S. in Electrical Engineering from the University of Illinois and a M.S. in Biomedical Engineering from Johns Hopkins University in Maryland. Wesley Park — Head of Global Clinical Research Programs Wesley Park is Head of Global Clinical Research Programs of Nevro Corp. with over a decade of neuromodulation and health care experience. During his time at Nevro, Mr. Park was crucial to developing company’s proprietary therapy algorithm and designing and overseeing key studies. Prior to joining Nevro, Mr. Park led clinical & marketing strategy at Boston Scientific Neuromodulation. Mr. Park received a Master of Public Health from Yale University and a B.A. in Molecular Biology from U.C. Berkeley. Tamara Rook — Vice President, Health Economics & Reimbursement Tamara Rook leads the health economics and reimbursement efforts for Nevro Corp. and brings nearly two decades of relevant experience to the organization. Prior to joining Nevro, Ms. Rook was the Vice President of Reimbursement at Vertos Medical where she focused on gaining market access for an emerging therapy. Prior to Vertos, Ms. Rook spent 8 years in the neuromodulation space with both Medtronic and Cyberonics where she was focused on managing patient access and initiating coverage for new indications. Ms. Rook has had a wide scope of reimbursement experience as she has also held leadership roles in both payer and provider organizations and executed both tactical and strategic reimbursement projects. Ms. Rook received a Master of Business Administration from the University of Houston and a Bachelor of Arts in Public Administration from Texas State University. Balakrishnan Shankar — Vice President, Operations Balakrishnan Shankar is Vice President of Operations at Nevro Corp. Mr. Shankar comes to Nevro with 25 years of diverse experience in life sustaining, class III active implantable medical devices such as implantable pacemakers and defibrillators. Mr. Shankar most recently spent 20 years at St. Jude Medical and has held a variety of leadership positions including Vice President of Operations and Vice President of Software Development, with responsibility for the development and manufacturing of its implantable pacemakers and defibrillators. Mr. Shankar received a B.S. in Electrical Engineering from the Indian Institute of Technology and an M.S. in Biomedical Engineering from Johns Hopkins University. Andre Walker — Senior Vice President, Research & Development Andre Walker joined Nevro Corp. as Vice President of Research and Development. Prior to joining Nevro, Mr. Walker spent 14 years at St. Jude Medical in various positions of which the last 8 years were as Vice President of R&D, responsible for the development of its implantable Defibrillators and Pacemaker products. Mr. Walker has also held leadership positions at Siemens Pacesetter and Zilog, Inc., a consumer semiconductor manufacturer. Mr. Walker holds a Master of Science in Electrical Engineering from the University of Hasselt in Belgium. HIGH-FREQUENCY SCS Nevro is developing a new high-frequency stimulation technology for chronic pain. Learn More » CONTACT US Questions? Please contact us for more information. Home | For Physicians | About Us | Newsroom | Contact Us © 2014 Nevro Corp. All rights reserved. Legal Notice | Patents | Privacy The Senza® SCS system is an investigational device in the United States. It is limited by U.S. law to investigational use only. Senza, HF10, Nevro, and the Nevro logo are trademarks of Nevro Corp.